Citadel Advisors LLC 13D and 13G filings for Lyra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 6:22 pm Sale |
2024-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Citadel Advisors LLC | 21,083 0.000% |
-4,265,844 (-99.51%) |
Filing |
| 2024-02-14 6:18 pm Purchase |
2023-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Citadel Advisors LLC | 4,286,927 7.900% |
1,390,392 (+48.00%) |
Filing |
| 2023-06-12 5:23 pm Purchase |
2023-05-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Citadel Advisors LLC | 2,896,535 5.900% |
2,896,535 (New Position) |
Filing |